Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial (Q35555922)

8 August 2017

title

Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial (English)

1 reference

8 August 2017

1 reference

18

Robert M Califf

1 reference

8 August 2017

Stephen E Kimmel

1

1 reference

8 August 2017

Benjamin French

2

1 reference

8 August 2017

Jeffrey L Anderson

3

1 reference

8 August 2017

Brian F Gage

4

1 reference

8 August 2017

Julie A Johnson

5

1 reference

8 August 2017

Yves D Rosenberg

6

1 reference

8 August 2017

Nancy L Geller

7

1 reference

8 August 2017

Scott E Kasner

8

1 reference

8 August 2017

Charles S Eby

9

1 reference

8 August 2017

Jungnam Joo

10

1 reference

8 August 2017

Michael D Caldwell

11

1 reference

8 August 2017

Samuel Z Goldhaber

12

1 reference

8 August 2017

Robert G Hart

13

1 reference

8 August 2017

Denise Cifelli

14

1 reference

8 August 2017

Rosemary Madigan

15

1 reference

8 August 2017

Colleen M Brensinger

16

1 reference

8 August 2017

Suzanne Goldberg

17

1 reference

8 August 2017

Jonas H Ellenberg

19

1 reference

8 August 2017

language of work or name

English

0 references

publication date

12 July 2013

1 reference

8 August 2017

published in

American Heart Journal

1 reference

8 August 2017

volume

166

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

435-441

1 reference

A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Emergency hospitalizations for adverse drug events in older Americans

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Prospective alpha allocation in the clarification of optimal anticoagulation through genetics (COAG) trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Integration of genetic, clinical, and INR data to refine warfarin dosing

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Genetic determinants of response to warfarin during initial anticoagulation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Idraparinux versus standard therapy for venous thromboembolic disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Validation of pharmacogenomic biomarker classifiers for treatment selection.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Incidence and preventability of adverse drug events among older persons in the ambulatory setting

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

A method to determine the optimal intensity of oral anticoagulant therapy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

A randomized controlled trial of genotype-based Coumadin initiation.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

No effect of encapsulation on the pharmacokinetics of warfarin

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415273

Hemorrhagic complications of anticoagulant treatment

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24016491

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Acutely injured patients on dabigatran

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24016491

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24016491

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.AHJ.2013.04.009

1 reference

8 August 2017

1 reference

8 August 2017

1 reference